References
1. Wang K, Harnden A, Perera R, Gill P, Thomson A, Mant D. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012; 10:CD009175.
2. Jain S, Williams DJ, Arnold SR, Ampofo K, Rolfs R. Community-acquired pneumonia requiring hospitalization among U.S. children. New England Journal of Medicine. 2015; 372:835.
3. Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2012; 17:5-9.
4. Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2012; 17.
5. Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, et al. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011. Euro Surveill. 2012.
6. Rasmussen JN, Voldstedlund M, Andersen RL, Ellermanneriksen S, Jensen TG, Johansen HK, et al. Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill. 2010; 15:2-5.
7. Lu CY, Yen TY, Chang LY, Liau YJ, Liu HH, Huang LM. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan. J Formos Med Assoc. 2020; 119:1539-45.
8. Zhao F, Li J, Liu J, Guan X, Gong J, Liu L, et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019; 8:143.
9. Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar C. Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Molecular Typing of Mycoplasma pneumoniae. Journal of Clinical Microbiology. 2009; 47:914-23.
10. Dumke R, Jacobs E. Culture-independent multi-locus variable-number tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae. Journal of Microbiological Methods. 2011; 86:393-6.
11. Alvaro J, Benitez, Maureen H, Diaz, Bernard J, Wolff, et al. Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. Journal of clinical microbiology. 2012.
12. Sun H, Xue G, Yan C, Li S, Ling C, Yi Y, et al. Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Clinical Specimens and Proposal for Amendment of MLVA Nomenclature. Plos One. 2013; 8:e64607.
13. Yan C, Sun H, Xue G, Zhao H, Wang L, Feng Y, et al. A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis. J Clin Microbiol. 2014; 52:4168-71.
14. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, et al. Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States. Open Forum Infect Dis. 2015; 2:ofv106.
15. Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012. Emerg Infect Dis. 2015; 21:426-34.
16. Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, et al. Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013; 8:e64607.
17. Xue G, Li M, Wang N, Zhao J, Wang B, Ren Z, et al. Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China. PLoS One. 2018; 13:e0198557.
18. Xue G, Li M, Wang N, Zhao J, Bei W, Ren Z, et al. Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China. PLoS ONE. 2018; 13:e0198557.
19. Yu S, Seto J, Shimotai Y. Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change of Molecular Characteristics during an 11-year Period. Japanese Journal of Infectious Diseases. 2017; 70.
20. Pak-Leung, Ho, Pierra, Law, Betsy, Chan, et al. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2. Journal of Clinical Microbiology. 2015.
21. Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, et al. Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012. Emerging Infectious Diseases. 2015; 21:426-34.
22. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, et al. Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States. Oxford University Press. 2015.
23. Whistler, Toni, Sawatwong, Pongpun, Diaz, Maureen H, et al. Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.
24. Xue G, Wang Q, Yan C, Jeoffreys N, Wang L, Li S, et al. Molecular Characterizations of PCR-Positive Mycoplasma pneumoniae Specimens Collected from Australia and China. Journal of Clinical Microbiology. 2014; 52.
25. Dumke R, Stolz S, Jacobs E, Juretzek T. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. International Journal of Infectious Diseases. 2014; 29:197-9.
26. Tsutomu I, Yu S, Junji S, Chieko A, Katsumi M, Yoko M. Two cases of macrolide resistance in Mycoplasma pneumoniae acquired during the treatment period. Journal of Antimicrobial Chemotherapy. 2013:724-5.
27. Cardinale F, Chironna M, Dumke R, Binetti A, aleno CD, Sallustio A, et al. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. European Respiratory Journal. 2011; 37:1522-4.
28. Yang TI, Chang T, Lu CY, Chen JM, Lee PI, Huang LM, et al. Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter? Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2018; 52.